Joe Poynton has never taken a coding course. Now, after picking up vibe coding, he's an app developer.
Pfizer Inc. (NYSE: PFE) today announced data from its Phase 2 study ( NCT06524414) evaluating the safety, tolerability and immunogenicity of a four-dose series of its investigational 25-valent ...
The deal, reportedly for more than $300 million, demonstrates Anthropic's continued interest in exercising greater control ...
What happens when a scientific problem seems too complex to solve precisely, yet understanding it could reshape how researchers design new materials and medicines? For decades, much of the polymer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results